tiprankstipranks
Trending News
More News >

James Scibetta Insider Profile

4 Followers
James Scibetta, President at Pacira Pharmaceuticals, holds 649.96K shares in Matinas BioPharma (Ticker: MTNB), holds 31.64K shares in Aquestive Therapeutics (Ticker: AQST), holds 27.08K shares in Pacira Pharmaceuticals (Ticker: PCRX).
tipranks
James Scibetta

James Scibetta
Pacira Pharmaceuticals (PCRX)
President

Ranked #29,303 out of 100,956 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+17.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
58.85%
33.36%
7.79%
A breakdown of James Scibetta's holdings

Insider Roles

Pacira Pharmaceuticals
(PCRX)
President
Matinas BioPharma
(MTNB)
Director
Aquestive Therapeutics
(AQST)
Director
Roles that James Scibetta holds in companies

Most Profitable Insider Trade

Stock:
Aquestive Therapeutics
(AQST)
Rating:Informative Buy
Date:Aug 22, 2019 - Aug 22, 2020
Return:+103.20%
The most profitable trade made by James Scibetta

James Scibetta's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Pacira Pharmaceuticals
Jun 07, 2017
President
Informative Sell
85.17K
$632.95K
Matinas BioPharma
Jun 24, 2021
Director
Uninformative Buy
$358.78K
Aquestive Therapeutics
Aug 22, 2019
Director
Informative Buy
86.87K
$83.83K
List of latest transactions for each holding click on a transaction to see James Scibetta's performance on stock

James Scibetta insider profile FAQ

What is the percentage of profitable transactions made by James Scibetta?
The percentage of profitable transactions made by James Scibetta is 67%.
    What is the average return per transaction made by James Scibetta?
    The average return per transaction made by James Scibetta is 17.50%.
      What stocks does James Scibetta hold?
      James Scibetta holds: PCRX, MTNB, AQST stocks.
        What was James Scibetta’s latest transaction?
        James Scibetta latest transaction was an Uninformative Buy of ―.
          What was James Scibetta's most profitable transaction?
          James Scibetta’s most profitable transaction was an Informative Buy of AQST stock on August 22, 2019. The return on the trade was 103.20%.
            What is James Scibetta's role in Pacira Pharmaceuticals?
            James Scibetta's role in Pacira Pharmaceuticals is President.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.